Laboratory & pharmaceutical research handbook

A grade names a document, not a rank

Method 625.1 in Appendix A to 40 CFR part 136 lists its reagents in one short section. Sodium hydroxide, sodium thiosulfate, sulfuric acid and sodium sulfate are called for as ACS. Acetone, methanol, methylene chloride and 2-propanol are called for as “High purity pesticide quality, or equivalent, demonstrated to be free of the analytes of interest and interferences.” One method, two different designations, chosen by what each reagent could contribute to the measurement—not by which grade sounds highest.

The same section then does something worth noticing. Its ACS-grade sodium sulfate must be “rinsed or Soxhlet extracted with methylene chloride (20 mL/g), baked in a shallow tray at 450 °C for one hour minimum, cooled in a desiccator” before use. A federal method takes a material that already meets a grade and requires further treatment anyway. A grade designation is a statement about what was tested; fitness for a particular determination is a separate question, and it stays with the person running the method.

Compendial standards are an instrument, not the top of a ladder

Under 21 U.S.C. 321(j) the term “official compendium” means the official United States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the United States, official National Formulary, or any supplement to any of them. That is a closed list, and what it does is point the statute at a particular set of documents for drug articles. It is not a league table of technical stringency, and ACS Reagent Chemicals is not weaker for being absent from it—it is a different instrument, written for analytical reagents, and it can control impurities a pharmacopeial monograph never addresses.

This is why a supposed hierarchy between designations breaks down as soon as it meets a real material. A substance may be covered by a specification in one system and have no counterpart in the other, in which case there is no ranking available to apply—only the question of which document your own process invokes. Never assume that swapping one designation for a “higher” one leaves a method unchanged. A nominal grade or concentration does not establish interchangeability between products or between suppliers.

Naming a grade creates the standard you are measured against

21 U.S.C. 351(b) provides that a drug is adulterated if it purports to be or is represented as a drug the name of which is recognized in an official compendium and its strength differs from, or its quality or purity falls below, the standard set forth in that compendium—and that the determination “shall be made in accordance with the tests or methods of assay set forth in such compendium.” The standard and the method that proves it arrive together. Paragraph (b) also carries an explicit escape: an article is not adulterated on this ground where its difference from the compendial standard “is plainly stated on its label.”

Paragraph (c) then covers everything outside (b): a material is judged against what “it purports or is represented to possess.” Read the two together and the discipline is the same in both directions. Claim less than you can show and nothing follows; claim a designation and you have written your own acceptance criteria. That is a reason to record the exact designation in a purchase document, and a reason never to widen it in prose afterwards.

• Which document and edition defines the designation being requested?
• Which attributes does it control, and which does it say nothing about?
• Is the value quoted a typical figure, a guaranteed specification limit, or a measured lot result?

A compendial method still has to work in your laboratory

21 CFR 211.194(a)(2) requires a statement of each method used and the location of the data establishing that the method meets proper standards of accuracy and reliability. Where the method sits in the current revision of the United States Pharmacopeia, National Formulary, AOAC INTERNATIONAL Book of Methods or another recognized standard reference and is not modified, “a statement indicating the method and reference will suffice.” The sentence that follows is the one that matters: “The suitability of all testing methods used shall be verified under actual conditions of use.”

A compendial reference saves a laboratory from re-validating a published procedure. It does not tell anyone that the procedure works on this matrix, at this concentration, on this instrument. And 211.194(b) requires complete records of any modification, with the reason and with data verifying that the modified method is at least as accurate and reliable. Where a supplier quotes a method, ask which revision, and whether it was run as published or adapted.

Say the grade you have, and nothing past it

Part 210 defines the vocabulary precisely. A “component” is any ingredient intended for use in the manufacture of a drug product. A “lot” is a batch, or a specific identified portion of a batch, having uniform character and quality within specified limits. “Strength” is the concentration of the drug substance, expressed for example on a weight/weight, weight/volume or unit dose/volume basis, and/or the potency. A grade designation is none of these things; it sits alongside them.

Alliance publishes the grade a product carries in its structured product data, and that record is what a purchase document should quote. Being listed under a laboratory or pharmaceutical collection is merchandising: an industry listing is not an application approval, and nothing here states that a particular Alliance product is suitable, approved or recommended for a method, a monograph or a regulated process. Where a grade is not stated for a product, the correct action is to ask—not to infer one from the copy.

Requirement → evidence → decision boundary

An editorial checklist for your review—not a table of product specifications.

Federal methods define reagent water by the measurement

Method 601 in Appendix A to 40 CFR part 136 puts it in one line: “Reagent water is defined as a water in which an interferent is not observed at the MDL of the parameters of interest.” Method 625.1 in the same appendix words it slightly differently—“water in which the analytes of interest and interfering compounds are not detected at the MDLs of the analytes of interest”—and means the same thing. Purity is not an absolute in either. It is a property held relative to a named list of analytes at a named detection limit.

Method 601 goes on to offer three ways to produce that water: a carbon filter bed, a water purification system, or boiling for 15 minutes followed by an hour of inert-gas sparging at 90 °C. Any of them qualifies, because the definition is a performance test rather than a production route. That is the useful inversion for a purchasing conversation. Write down what must not be present and at what level, and the acceptable ways of getting there fall out of it; start from a type name and you have skipped the requirement.

An instrument answers only the question it asks

FDA’s inspection guide for high purity water systems states it flatly: “Typically, conductivity meters are used on water systems to monitor chemical quality and have no meaning regarding microbiological quality.” Elsewhere it adds that “Because of the similar ionic quality of distilled and deionized water, conductivity meters cannot be used to monitor microbiological quality.” Resistivity and conductivity are the same measurement reciprocated, and neither one sees an organism or an uncharged organic molecule.

The same guide records that “different products require different quality waters,” contrasting parenterals, which require water with no endotoxins, against topical and oral products, which it says have no endotoxin requirement. Three properties, three instruments, three sampling regimes—and a specification that names only one of them has left the others undefined rather than satisfied. Note the document’s own limits: it was issued in July 1993, it says on its face that it “does not bind FDA,” and it cites USP XXII, a revision superseded many times over. Its reasoning is durable; its numbers are not a current requirement and must not be quoted as one.

A grab sample is not the system

The same guide explains why a single water result is weak evidence. Organisms attach to pipe and tank walls as biofilm, “which continuously slough off organisms,” so “contamination is not uniformly distributed in a system and the sample may not be representative of the type and level of contamination.” It offers the scale of the effect directly: “A count of 10 CFU/mL in one sample and 100 or even 1000 CFU/mL in a subsequent sample would not be unrealistic.”

It also draws a distinction worth importing into any water specification: “None of the limits for water are pass/fail limits. All limits are action limits,” with an expectation that an exceedance triggers an investigation, a correction and an assessment of impact. A limit with no named owner for that investigation is not yet a control. Decide before the first result who reviews an exceedance and what happens to material already made.

• Which property would actually ruin this step—ionic, organic, microbiological, or particulate?
• At what point in the system is each property measured, and how often?
• Is each limit a specification or an action limit, and who investigates an exceedance?
• Where water is delivered rather than generated on site, which properties are known at the point of use rather than at the point of manufacture?

What this guide will not reproduce

The reagent-water type framework most laboratories quote—Types I through IV—is defined by ASTM D1193, and clinical laboratories work to a separate document published by CLSI. Both are copyrighted standards sold by their publishers. Neither was readable while this guide was written, so neither is cited here and none of their numeric limits are reproduced. Take the limits from the edition of the standard your own specification invokes and that your team actually holds.

That is not a gap to paper over with a plausible-looking table. A type designation copied from memory, or from a supplier’s marketing page, is exactly the sort of number that survives into a specification and is never checked again. Name the standard, name the edition, and record the properties you require with their units and methods beside it. Where a value is taken from a document nobody on the project has opened, write that down too.

Requirement → evidence → decision boundary

An editorial checklist for your review—not a table of product specifications.

Ask for the certificate, and say which one

Alliance sends a Certificate of Analysis when a customer asks, at no charge. Put the request in the purchase order and name the document you mean. A sample or typical certificate describes what the product has generally looked like; a lot certificate reports results for the material being shipped to you. A sample COA is not a lot certificate, and in a records file the two are not interchangeable.

Part 210 supplies the two definitions that decide what a lot certificate is worth. A “lot” is a batch, or a specific identified portion of a batch, “having uniform character and quality within specified limits.” A “representative sample” is one “drawn based on rational criteria such as random sampling and intended to assure that the sample accurately portrays the material being sampled.” A certificate reports a result from a sample; the certificate itself rarely states the sampling plan behind it. If the uniformity of the lot matters to you, that is a question to ask, not to assume.

The rule that allows a supplier certificate never lets it stand alone

21 CFR 211.84(d)(2) is the provision usually meant by “we accept the COA.” Read in full it says each component shall be tested for conformity with all appropriate written specifications for purity, strength and quality, and that “In lieu of such testing by the manufacturer, a report of analysis may be accepted from the supplier of a component, provided that at least one specific identity test is conducted on such component by the manufacturer, and provided that the manufacturer establishes the reliability of the supplier’s analyses through appropriate validation of the supplier’s test results at appropriate intervals.”

Two obligations survive the certificate, and both sit with the receiving party. 211.84(d)(1) requires at least one test to verify identity, using a specific identity test where one exists. And 211.84(a) holds each lot from use until it has been sampled, tested or examined and released by the quality control unit. Alliance cannot perform your identity test, cannot validate your supplier-reliability programme, and does not make your release decision. Nothing in a certificate we send establishes compliance with cGMP on a customer’s behalf.

A checklist for reading someone else’s number

21 CFR 211.194(a) lists what a regulated laboratory record must contain, and the list works well as a reading guide for any certificate. A description of the sample with its source, quantity, lot number and the dates it was taken and received. A statement of each method used. The weight or measure of sample used. A complete record of all data secured, including graphs, charts and spectra. All calculations, “including units of measure, conversion factors, and equivalency factors.” A statement of the results and how they compare with established standards of identity, strength, quality and purity. The initials of the person who performed each test, and of a second person who reviewed the record.

A supplier certificate is not a 211.194 record and will not carry all of this. That is the point of reading it against the list: what is missing becomes visible and can be recorded as missing rather than assumed. Every numeric value you keep should end up with its units, its conditions, its basis, and the document and revision it came from. Where a certificate reports a result below a reporting limit, that is a limit and not a zero—and an analyte that was never on the list is not a demonstrated absence.

• Is this a typical/sample certificate, or a result for the lot being shipped?
• Which analytes, methods, units and reporting limits does it cover?
• Are the entries actual results, or statements that the material conforms?
• Which of your specification requirements does it not address at all?

Supplier qualification, written out in steps

The dietary-supplement cGMP rule spells out the same idea in more detail than part 211 does, and it is instructive even where it does not apply. 21 CFR 111.75(a)(2)(ii) permits reliance on a supplier’s certificate of analysis only where five conditions hold: the supplier has first been qualified “by establishing the reliability of the supplier’s certificate of analysis through confirmation of the results of the supplier’s tests or examinations”; the certificate “includes a description of the test or examination method(s) used, limits of the test or examinations, and actual results”; documentation of how the supplier was qualified is maintained; the certificate is periodically re-confirmed; and quality control personnel review and approve the basis for qualification. Identity testing is separate again—111.75(a)(1)(i) requires at least one appropriate test or examination for any component that is a dietary ingredient, and the only route around it is a petition to the agency.

“Actual results” is the phrase to carry into a purchasing conversation. A certificate that returns “conforms”, “complies” or “pass” against a specification has reported a judgement, not a measurement, and it cannot be re-examined later against a different limit. A monograph or a specification fixes attributes and the tests that prove them; it says nothing about whether the material suits your equipment, your container, your hold time or your process. Those remain the buyer’s to determine, with their own specialist. This is source-based editorial guidance, not a qualification of any product for any use, and independent specialist review of this collection is pending.

Requirement → evidence → decision boundary

An editorial checklist for your review—not a table of product specifications.